<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35049914</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-3397</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>Marine drugs</Title><ISOAbbreviation>Mar Drugs</ISOAbbreviation></Journal><ArticleTitle>Influence of the Structural Features of Carrageenans from Red Algae of the Far Eastern Seas on Their Antiviral Properties.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">60</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/md20010060</ELocationID><Abstract><AbstractText>The structural diversity and unique physicochemical properties of sulphated polysaccharides of red algae carrageenans (CRGs), to a great extent, determine the wide range of their antiviral properties. This work aimed to compare the antiviral activities of different structural types of CRGs: against herpes simplex virus type 1 (HSV-1) and enterovirus (ECHO-1). We found that CRGs significantly increased the resistance of Vero cells to virus infection (preventive effect), directly affected virus particles (virucidal effect), inhibited the attachment and penetration of virus to cells, and were more effective against HSV-1. CRG1 showed the highest virucidal effect on HSV-1 particles with a selective index (SI) of 100. CRG2 exhibited the highest antiviral activity by inhibiting HSV-1 and ECHO-1 plaque formation, with a SI of 110 and 59, respectively, when it was added before virus infection. CRG2 also significantly reduced the attachment of HSV-1 and ECHO-1 to cells compared to other CRGs. It was shown by molecular docking that tetrasaccharides-CRGs are able to bind with the HSV-1 surface glycoprotein, gD, to prevent virus-cell interactions. The revealed differences in the effect of CRGs on different stages of the lifecycle of the viruses are apparently related to the structural features of the investigated compounds.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krylova</LastName><ForeName>Natalia V</ForeName><Initials>NV</Initials><Identifier Source="ORCID">0000-0002-9048-6803</Identifier><AffiliationInfo><Affiliation>G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kravchenko</LastName><ForeName>Anna O</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iunikhina</LastName><ForeName>Olga V</ForeName><Initials>OV</Initials><Identifier Source="ORCID">0000-0002-6723-582X</Identifier><AffiliationInfo><Affiliation>G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pott</LastName><ForeName>Anastasia B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhatskaya</LastName><ForeName>Galina N</ForeName><Initials>GN</Initials><Identifier Source="ORCID">0000-0003-1937-1680</Identifier><AffiliationInfo><Affiliation>G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volod'ko</LastName><ForeName>Aleksandra V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaporozhets</LastName><ForeName>Tatyana S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shchelkanov</LastName><ForeName>Mikhail Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, 690087 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yermak</LastName><ForeName>Irina M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>project № 21-74-20019</GrantID><Agency>Russian Science Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Mar Drugs</MedlineTA><NlmUniqueID>101213729</NlmUniqueID><ISSNLinking>1660-3397</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9000-07-1</RegistryNumber><NameOfSubstance UI="D002351">Carrageenan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059001" MajorTopicYN="N">Aquatic Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002351" MajorTopicYN="N">Carrageenan</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018259" MajorTopicYN="N">Herpesvirus 1, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000461" MajorTopicYN="Y">Rhodophyta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carrageenan</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">herpes simplex virus type 1</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35049914</ArticleId><ArticleId IdType="pmc">PMC8779503</ArticleId><ArticleId IdType="doi">10.3390/md20010060</ArticleId><ArticleId IdType="pii">md20010060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Luescher-Mattli M. Algae, A Possible Source for New Drugs in the Treatment of HIV and Other Viral Diseases. Curr. Med. Chem.-Anti-Infect. Agents. 2003;2:219–225. doi: 10.2174/1568012033483051.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568012033483051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo D.-H., Kim S.-K. Sulfated polysaccharides as bioactive agents from marine algae. Int. J. Biol. Macromol. 2013;62:70–75. doi: 10.1016/j.ijbiomac.2013.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2013.08.036</ArticleId><ArticleId IdType="pubmed">23994790</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang S.-X., Guan H.-S. The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview. Mar. Drugs. 2012;10:2795–2816. doi: 10.3390/md10122795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md10122795</ArticleId><ArticleId IdType="pmc">PMC3528127</ArticleId><ArticleId IdType="pubmed">23235364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi A., Zorofchian Moghadamtousi S., Abubakar S., Zandi K. Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review. Biomed Res. Int. 2015;2015:1–10. doi: 10.1155/2015/825203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/825203</ArticleId><ArticleId IdType="pmc">PMC4592888</ArticleId><ArticleId IdType="pubmed">26484353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgougnon N. Anti-HIV compounds from red seaweeds. In: Fingerman M., Nagabhushanam R., editors. Recent Advances in Marine Biotechnology. Volume 9. Science Publisher Inc.; Enfield, NH, USA: Plymouth, UK: 2003. pp. 165–206.</Citation></Reference><Reference><Citation>Álvarez-Viñas M., Souto S., Flórez-Fernández N., Torres M.D., Bandín I., Domínguez H. Antiviral activity of carrageenans and processing implications. Mar. Drugs. 2021;19:437. doi: 10.3390/md19080437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md19080437</ArticleId><ArticleId IdType="pmc">PMC8400836</ArticleId><ArticleId IdType="pubmed">34436276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne K.Z., Bourne N., Reising S.F., Stanberry L.R. Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antivir. Res. 1999;42:219–226. doi: 10.1016/S0166-3542(99)00020-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(99)00020-0</ArticleId><ArticleId IdType="pubmed">10443534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., Ghosh K., Hahn F., Wangen C., Strojan H., Müller R., Anand N., Ali I., Bera K., Ray B., et al. Chemically sulfated polysaccharides from natural sources: Assessment of extraction-sulfation efficiencies, structural features and antiviral activities. Int. J. Biol. Macromol. 2019;136:521–530. doi: 10.1016/j.ijbiomac.2019.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.05.005</ArticleId><ArticleId IdType="pubmed">31158418</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng K., Groth T., Zhang K. Recent Advances in Artificially Sulfated Polysaccharides for Applications in Cell Growth and Differentiation, Drug Delivery, and Tissue Engineering. ChemBioChem. 2019;20:737–746. doi: 10.1002/cbic.201800569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201800569</ArticleId><ArticleId IdType="pubmed">30394659</ArticleId></ArticleIdList></Reference><Reference><Citation>Van De Velde F., Lourenço N.D., Pinheiro H.M., Bakker M. Carrageenan: A Food-Grade and Biocompatible Support for Immobilisation Techniques. Adv. Synth. Catal. 2002;344:815–835. doi: 10.1002/1615-4169(200209)344:8&lt;815::AID-ADSC815&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1615-4169(200209)344:8&lt;815::AID-ADSC815&gt;3.0.CO;2-H</ArticleId></ArticleIdList></Reference><Reference><Citation>Yermak I., Khotimchenko Y. Chemical properties, biological activities and the applications of carrageenan from red algae. In: Fingerman M., Nagabhushanam R., editors. Recent Advances in Marine Biotechnology. Volume 9. Science Publisher Inc.; Enfield, NH, USA: Plymouth, UK: 2003. pp. 207–255.</Citation></Reference><Reference><Citation>Baba M., Snoeck R., Pauwels R., De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Chemother. 1988;32:1742–1745. doi: 10.1128/AAC.32.11.1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.32.11.1742</ArticleId><ArticleId IdType="pmc">PMC175964</ArticleId><ArticleId IdType="pubmed">2472775</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlucci M.J., Ciancia M., Matulewicz M.C., Cerezo A.S., Damonte E.B. Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antivir. Res. 1999;43:93–102. doi: 10.1016/S0166-3542(99)00038-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(99)00038-8</ArticleId><ArticleId IdType="pubmed">10517311</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulho R., Marty C., Freile-Pelegrín Y., Robledo D., Bourgougnon N., Bedoux G. Antiherpetic (HSV-1) activity of carrageenans from the red seaweed Solieria chordalis (Rhodophyta, Gigartinales) extracted by microwave-assisted extraction (MAE) J. Appl. Phycol. 2017;29:2219–2228. doi: 10.1007/s10811-017-1192-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10811-017-1192-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlucci M., Scolaro L., Noseda M., Cerezo A., Damonte E. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antivir. Res. 2004;64:137–141. doi: 10.1016/j.antiviral.2004.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2004.07.001</ArticleId><ArticleId IdType="pubmed">15498610</ArticleId></ArticleIdList></Reference><Reference><Citation>Harden E.A., Falshaw R., Carnachan S.M., Kern E.R., Prichard M.N. Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antivir. Res. 2009;83:282–289. doi: 10.1016/j.antiviral.2009.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.06.007</ArticleId><ArticleId IdType="pmc">PMC2730659</ArticleId><ArticleId IdType="pubmed">19576248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T., Ogamo A., Saito T., Uchiyama H., Nakagawa Y. Preparation of O-acylated low-molecular-weight carrageenans with potent anti-HIV activity and low anticoagulant effect. Carbohydr. Polym. 2000;41:115–120. doi: 10.1016/S0144-8617(99)00083-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0144-8617(99)00083-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Haaland R.E., Chaowanachan T., Evans-Strickfaden T., van de Wijgert J.H., Kilmarx P.H., McLean C.A., Hart C.E. Carrageenan-Based Gel Retains Limited Anti-HIV-1 Activity 8–24 Hours After Vaginal Application by HIV-Infected Thai Women Enrolled in a Phase I Safety Trial. JAIDS J. Acquir. Immune Defic. Syndr. 2012;61:e71–e73. doi: 10.1097/QAI.0b013e318271c8f9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0b013e318271c8f9</ArticleId><ArticleId IdType="pmc">PMC5549010</ArticleId><ArticleId IdType="pubmed">23183152</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibbrandt A., Meier C., König-Schuster M., Weinmüllner R., Kalthoff D., Pflugfelder B., Graf P., Frank-Gehrke B., Beer M., Fazekas T., et al. Iota-carrageenan is a potent inhibitor of influenza a virus infection. PLoS ONE. 2010;5:e14320. doi: 10.1371/journal.pone.0014320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014320</ArticleId><ArticleId IdType="pmc">PMC3001860</ArticleId><ArticleId IdType="pubmed">21179403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhang P., Hao C., Zhang X.E., Cui Z.Q., Guan H.S. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antivir. Res. 2011;92:237–246. doi: 10.1016/j.antiviral.2011.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.08.010</ArticleId><ArticleId IdType="pubmed">21867732</ArticleId></ArticleIdList></Reference><Reference><Citation>Besednova N.N., Zvyagintseva T.N., Kuznetsova T.A., Makarenkova I.D., Smolina T.P., Fedyanina L.N., Kryzhanovsky S.P., Zaporozhets T.S. Marine algae metabolites as promising therapeutics for the prevention and treatment of HIV/AIDS. Metabolites. 2019;9:87. doi: 10.3390/metabo9050087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo9050087</ArticleId><ArticleId IdType="pmc">PMC6572556</ArticleId><ArticleId IdType="pubmed">31052506</ArticleId></ArticleIdList></Reference><Reference><Citation>Talarico L.B., Noseda M.D., Ducatti D.R.B., Duarte M.E.R., Damonte E.B. Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan. J. Gen. Virol. 2011;92:1332–1342. doi: 10.1099/vir.0.028522-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.028522-0</ArticleId><ArticleId IdType="pubmed">21325483</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimyte E.M., Smith S.E., Oreste P., Lembo D., Dutch R.E. Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues. J. Virol. 2016;90:9237–9250. doi: 10.1128/JVI.01362-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01362-16</ArticleId><ArticleId IdType="pmc">PMC5044844</ArticleId><ArticleId IdType="pubmed">27489270</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z., Tian D., Zhou M., Xiao W., Zhang Y., Li M., Sui B., Wang W., Guan H., Chen H., et al. λ-Carrageenan P32 Is a Potent Inhibitor of Rabies Virus Infection. PLoS ONE. 2015;10:e0140586. doi: 10.1371/journal.pone.0140586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140586</ArticleId><ArticleId IdType="pmc">PMC4605673</ArticleId><ArticleId IdType="pubmed">26465753</ArticleId></ArticleIdList></Reference><Reference><Citation>Frediansyah A. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review. Clin. Epidemiol. Glob. Heal. 2021;12:100826. doi: 10.1016/j.cegh.2021.100826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2021.100826</ArticleId><ArticleId IdType="pmc">PMC8240443</ArticleId><ArticleId IdType="pubmed">34222718</ArticleId></ArticleIdList></Reference><Reference><Citation>Morokutti-Kurz M., Fröba M., Graf P., Große M., Grassauer A., Auth J., Schubert U., Prieschl-Grassauer E. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro. PLoS ONE. 2021;16:e0237480. doi: 10.1371/journal.pone.0237480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237480</ArticleId><ArticleId IdType="pmc">PMC7888609</ArticleId><ArticleId IdType="pubmed">33596218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Y.H., Chan Y.L., Tsai L.W., Li T.L., Wu C.J. Prevention of human enterovirus 71 infection by kappa carrageenan. Antivir. Res. 2012;95:128–134. doi: 10.1016/j.antiviral.2012.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.05.009</ArticleId><ArticleId IdType="pubmed">22643729</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurie C., El-Zein M., Coutlée F., De Pokomandy A., Franco E.L. Carrageenan as a Preventive Agent against Human Papillomavirus Infection: A Narrative Review. Sex. Transm. Dis. 2021;48:458–465. doi: 10.1097/OLQ.0000000000001363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/OLQ.0000000000001363</ArticleId><ArticleId IdType="pubmed">33433173</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassauer A., Weinmuellner R., Meier C., Pretsch A., Prieschl-Grassauer E., Unger H. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol. J. 2008;5:107. doi: 10.1186/1743-422X-5-107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-5-107</ArticleId><ArticleId IdType="pmc">PMC2562995</ArticleId><ArticleId IdType="pubmed">18817582</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles R., Winther B., Johnston S.L., Robinson P., Trampisch M., Koelsch S. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: The ICICC trial. Respir. Res. 2015;16:1–11. doi: 10.1186/s12931-015-0281-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-015-0281-8</ArticleId><ArticleId IdType="pmc">PMC4595062</ArticleId><ArticleId IdType="pubmed">26438038</ArticleId></ArticleIdList></Reference><Reference><Citation>Matloub A.A., Elsouda S.S.M., El-Senousy W.M., Hamed M., Aly H., Ali S.A., Mohammed R.S., Mahmoud K., El-Hallouty S., Ibrahim N.A., et al. In vitro antiviral, cytotoxic, antioxidant and hypolipidemic activites of polysaccharide isolated from marine algae. Int. J. Pharmacogn. Phytochem. Res. 2015;7:1099–1111.</Citation></Reference><Reference><Citation>Jabeen M., Dutot M., Fagon R., Verrier B., Monge C. Seaweed sulfated polysaccharides against respiratory viral infections. Pharmaceutics. 2021;13:733. doi: 10.3390/pharmaceutics13050733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13050733</ArticleId><ArticleId IdType="pmc">PMC8156470</ArticleId><ArticleId IdType="pubmed">34065660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges. Mar. Drugs. 2020;18:435. doi: 10.3390/md18090435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md18090435</ArticleId><ArticleId IdType="pmc">PMC7551811</ArticleId><ArticleId IdType="pubmed">32825645</ArticleId></ArticleIdList></Reference><Reference><Citation>Reunov A., Nagorskaya V., Lapshina L., Yermak I., Barabanova A. Effect of κ/β-Carrageenan from red alga Tichocarpus crinitus (Tichocarpaceae) on infection of detached tobacco leaves with tobacco mosaic virus. J. Plant Dis. Prot. 2004;111:165–172. doi: 10.1007/BF03356143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03356143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalitnik A.A., Byankina Barabanova A.O., Nagorskaya V.P., Reunov A.V., Glazunov V.P., Solov’eva T.F., Yermak I.M. Low molecular weight derivatives of different carrageenan types and their antiviral activity. J. Appl. Phycol. 2013;25:65–72. doi: 10.1007/s10811-012-9839-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10811-012-9839-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Velde F., Knutsen S.H., Usov A.I., Rollema H.S., Cerezo A.S. 1H and 13C high resolution NMR spectroscopy of carrageenans: Application in research and industry. Trends Food Sci. Technol. 2002;13:73–92. doi: 10.1016/S0924-2244(02)00066-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0924-2244(02)00066-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira L., Amado A.M., Critchley A.T., van de Velde F., Ribeiro-Claro P.J.A. Identification of selected seaweed polysaccharides (phycocolloids) by vibrational spectroscopy (FTIR-ATR and FT-Raman) Food Hydrocoll. 2009;23:1903–1909. doi: 10.1016/j.foodhyd.2008.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodhyd.2008.11.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Yermak I.M., Kim Y.H., Titlynov E.A., Isakov V.V., Solov’eva T.F. Chemical structure and gel properties of carrageenans from algae belonging to the Gigartinaceae and Tichocarpaceae, collected from the Russian Pacific Coast. J. Appl. Phycol. 1999;11:41–48. doi: 10.1023/A:1008071925884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1008071925884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko A.O., Anastyuk S.D., Isakov V.V., Sokolova E.V., Glazunov V.P., Yermak I.M. Structural peculiarities of polysaccharide from sterile form of Far Eastern red alga Ahnfeltiopsis flabelliformis. Carbohydr. Polym. 2014;111:1–9. doi: 10.1016/j.carbpol.2014.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2014.04.022</ArticleId><ArticleId IdType="pubmed">25037322</ArticleId></ArticleIdList></Reference><Reference><Citation>Barabanova A.O., Yermak I.M., Glazunov V.P., Isakov V.V., Titlyanov E.A., Solov’eva T.F. Comparative study of carrageenans from reproductive and sterile forms of Tichocarpus crinitus (Gmel.) Rupr (Rhodophyta, Tichocarpaceae) Biochemistry. 2005;70:350–356. doi: 10.1007/s10541-005-0121-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10541-005-0121-4</ArticleId><ArticleId IdType="pubmed">15823090</ArticleId></ArticleIdList></Reference><Reference><Citation>Correc G., Barabanova A., Tuvikene R., Truus K., Yermak I., Helbert W. Comparison of the structures of hybrid κ/β-carrageenans extracted from Furcellaria lumbricalis and Tichocarpus crinitus. Carbohydr. Polym. 2012;88:31–36. doi: 10.1016/j.carbpol.2011.11.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2011.11.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko A.O., Anastyuk S.D., Sokolova E.V., Isakov V.V., Glazunov V.P., Helbert W., Yermak I.M. Structural analysis and cytokine-induced activity of gelling sulfated polysaccharide from the cystocarpic plants of Ahnfeltiopsis flabelliformis. Carbohydr. Polym. 2016;151:523–534. doi: 10.1016/j.carbpol.2016.05.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2016.05.086</ArticleId><ArticleId IdType="pubmed">27474596</ArticleId></ArticleIdList></Reference><Reference><Citation>Indrayanto G., Putra G.S., Suhud F. Validation of In-Vitro Bioassay Methods: Application in Herbal Drug Research. Profiles Drug Subst. Excip. Relat. Methodol. 2021;46:273–307.</Citation><ArticleIdList><ArticleId IdType="pubmed">33461699</ArticleId></ArticleIdList></Reference><Reference><Citation>Arii J., Kawaguchi Y. The Role of HSV Glycoproteins in Mediating Cell Entry. Springer; Singapore: 2018. pp. 3–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29896660</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Donnell C.D., Kovacs M., Akhtar J., Valyi-Nagy T., Shukla D. Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry. Virology. 2010;397:389–398. doi: 10.1016/j.virol.2009.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.11.011</ArticleId><ArticleId IdType="pmc">PMC3351100</ArticleId><ArticleId IdType="pubmed">20004926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishchenko N.P., Krylova N.V., Iunikhina O.V., Vasileva E.A., Likhatskaya G.N., Pislyagin E.A., Tarbeeva D.V., Dmitrenok P.S., Fedoreyev S.A. Antiviral Potential of Sea Urchin Aminated Spinochromes against Herpes Simplex Virus Type 1. Mar. Drugs. 2020;18:550. doi: 10.3390/md18110550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md18110550</ArticleId><ArticleId IdType="pmc">PMC7694471</ArticleId><ArticleId IdType="pubmed">33167501</ArticleId></ArticleIdList></Reference><Reference><Citation>Damonte E., Matulewicz M., Cerezo A. Sulfated Seaweed Polysaccharides as Antiviral Agents. Curr. Med. Chem. 2004;11:2399–2419. doi: 10.2174/0929867043364504.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867043364504</ArticleId><ArticleId IdType="pubmed">15379705</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Velde F. Structure and function of hybrid carrageenans. Food Hydrocoll. 2008;22:727–734. doi: 10.1016/j.foodhyd.2007.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodhyd.2007.05.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Stortz C.A. Handbook of Carbohydrate Engineering. CRC Press; Boca Raton, FL, USA: 2005. Carrageenans: Structural and conformational studies; pp. 211–246.</Citation></Reference><Reference><Citation>Sokolova E.V., Barabanova A.O., Homenko V.A., Solov’eva T.F., Bogdanovich R.N., Yermak I.M. In Vitro and Ex Vivo Studies of Antioxidant Activity of Carrageenans, Sulfated Polysaccharides from Red Algae. Bull. Exp. Biol. Med. 2011;150:426–428. doi: 10.1007/s10517-011-1159-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10517-011-1159-5</ArticleId><ArticleId IdType="pubmed">22268034</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastyuk S.D., Barabanova A.O., Correc G., Nazarenko E.L., Davydova V.N., Helbert W., Dmitrenok P.S., Yermak I.M. Analysis of structural heterogeneity of κ/β-carrageenan oligosaccharides from Tichocarpus crinitus by negative-ion ESI and tandem MALDI mass spectrometry. Carbohydr. Polym. 2011;86:546–554. doi: 10.1016/j.carbpol.2011.04.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2011.04.081</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte M.E.R., Noseda D.G., Noseda M.D., Tulio S., Pujol C.A., Damonte E.B. Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phytomedicine. 2001;8:53–58. doi: 10.1078/0944-7113-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0944-7113-00007</ArticleId><ArticleId IdType="pubmed">11292240</ArticleId></ArticleIdList></Reference><Reference><Citation>Yermak I.M., Davydova V.N., Kravchenko A.O., Chistyulin D.A., Pimenova E.A., Glazunov V.P. Mucoadhesive properties of sulphated polysaccharides carrageenans from red seaweed families Gigartinaceae and Tichocarpaceae. Int. J. Biol. Macromol. 2020;142:634–642. doi: 10.1016/j.ijbiomac.2019.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.10.005</ArticleId><ArticleId IdType="pubmed">31622715</ArticleId></ArticleIdList></Reference><Reference><Citation>Talarico L.B., Zibetti R.G., Faria P.C., Scolaro L.A., Duarte M.E., Noseda M.D., Pujol C.A., Damonte E.B. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Int. J. Biol. Macromol. 2004;34:63–71. doi: 10.1016/j.ijbiomac.2004.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2004.03.002</ArticleId><ArticleId IdType="pubmed">15178011</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Velde F., Peppelman H.A., Rollema H.S., Tromp R.H. On the structure of κ/ι-hybrid carrageenans. Carbohydr. Res. 2001;331:271–283. doi: 10.1016/S0008-6215(01)00054-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6215(01)00054-4</ArticleId><ArticleId IdType="pubmed">11383897</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlucci M.J., Pujol C.A., Ciancia M., Noseda M.D., Matulewicz M.C., Damonte E.B., Cerezo A.S. Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: Correlation between structure and biological activity. Int. J. Biol. Macromol. 1997;20:97–105. doi: 10.1016/S0141-8130(96)01145-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0141-8130(96)01145-2</ArticleId><ArticleId IdType="pubmed">9184941</ArticleId></ArticleIdList></Reference><Reference><Citation>Usov A.I., Elashvili M.Y. Investigation of Sulfated Galactan from Laurencia nipponica Yamada (Rhodophyta, Rhodomelaceae) Using Partial Reductive Hydrolysis. Bot. Mar. 1991;34:553–560. doi: 10.1515/botm.1991.34.6.553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/botm.1991.34.6.553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko A.O., Anastyuk S.D., Glazunov V.P., Sokolova E.V., Isakov V.V., Yermak I.M. Structural characteristics of carrageenans of red alga Mastocarpus pacificus from sea of Japan. Carbohydr. Polym. 2020;229:115518. doi: 10.1016/j.carbpol.2019.115518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2019.115518</ArticleId><ArticleId IdType="pubmed">31826457</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodgson K., Price R. A note on the determination of the ester sulphate content of sulphated polysaccharides. Biochem. J. 1962;84:106–110. doi: 10.1042/bj0840106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj0840106</ArticleId><ArticleId IdType="pmc">PMC1243628</ArticleId><ArticleId IdType="pubmed">13886865</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochas C., Rinaudo M., Landry S. Role of the molecular weight on the mechanical properties of kappa carrageenan gels. Carbohydr. Polym. 1990;12:255–266. doi: 10.1016/0144-8617(90)90067-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0144-8617(90)90067-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.T., Johnson M.J. A submicrodetermination of glucose. J. Biol. Chem. 1949;181:149–151. doi: 10.1016/S0021-9258(18)56635-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)56635-7</ArticleId><ArticleId IdType="pubmed">15390401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(83)90303-4</ArticleId><ArticleId IdType="pubmed">6606682</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott A.B., Krylova N.V., Kravchenko A.O., Yermak I.M., Lavrov V.F. Activity of carraginanes from red algae for infections caused by the herpes simplex virus. Sanit. Vrač (Sanit. Dr.) 2020. pp. 10–20.</Citation><ArticleIdList><ArticleId IdType="doi">10.33920/med-08-2009-01</ArticleId></ArticleIdList></Reference><Reference><Citation>Killington R.A., Powell K.L. Growth, Assay, and Purification of Herpesviruses. In: Mahy B.W., editor. Virology: A Practical Approach. IRL Press; Oxford, UK: 1991.</Citation></Reference><Reference><Citation>Marcocci M.E., Amatore D., Villa S., Casciaro B., Aimola P., Franci G., Grieco P., Galdiero M., Palamara A.T., Mangoni M.L., et al. The amphibian antimicrobial peptide temporin b inhibits in vitro herpes simplex virus 1 infection. Antimicrob. Agents Chemother. 2018;62 doi: 10.1128/AAC.02367-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02367-17</ArticleId><ArticleId IdType="pmc">PMC5923125</ArticleId><ArticleId IdType="pubmed">29483113</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Wu Y., Bi J., Wang S., Li F., Kong W., Barbier J., Cintrat J.-C., Gao F., Gillet D., et al. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo. Viruses. 2018;10:119. doi: 10.3390/v10030119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10030119</ArticleId><ArticleId IdType="pmc">PMC5869512</ArticleId><ArticleId IdType="pubmed">29522484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>